I agree that this site is using cookies. You can find further informations here.
X
Delaloge Suzette
469  results:
Search for persons X
?
1

Breast cancer survivors' opinion on personalizing endocrine..:

Rassy, Elie ; Benvenuti, Chiara ; Akla, Sarra...
npj Breast Cancer.  10 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Ductal carcinoma in situ of the breast: finding the balance..:

Delaloge, Suzette ; Khan, Seema Ahsan ; Wesseling, Jelle.
The Lancet.  403 (2024)  10445 - p. 2734-2746 , 2024
Link: https://doi.org/10.1016/..
 
?
3

First-line real-world treatment patterns and survival outco..:

Galvin, Angéline ; Courtinard, Coralie ; Bouteiller, Fanny...
European Journal of Cancer.  196 (2024)  - p. 113422 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Effective treatment based on monitoring bESR1 mutations – A..:

Bidard, Francois-Clément ; Hardy-Bessard, Anne-Claire ; Delaloge, Suzette
The Lancet Oncology.  24 (2023)  1 - p. e4 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Disease-free survival does not differ according to fertilit..:

Sonigo, Charlotte ; Amsellem, Noémi ; Mayeur, Anne...
Fertility and Sterility.  119 (2023)  3 - p. 465-473 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Facing points of view: Representations on adjuvant endocrin..:

Roche, Nicolas ; Le Provost, Jean-Bernard ; Borinelli-Franzoi, Maria-Alice...
European Journal of Oncology Nursing.  62 (2023)  - p. 102259 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Real-World Diagnostic Accuracy of the On-Site Cytopathology..:

Suciu, Voichita ; El Chamieh, Carolla ; Soufan, Ranya...
Cancers.  15 (2023)  20 - p. 4967 , 2023
Link: https://doi.org/10.3390/..
 
?
8

Target trial emulation to assess real-world efficacy in the..:

Antoine, Alison ; Pérol, David ; Robain, Mathieu...
JNCI: Journal of the National Cancer Institute.  115 (2023)  8 - p. 971-980 , 2023
Link: https://doi.org/10.1093/..
 
?
9

OlympiAD extended follow-up for overall survival and safety..:

Robson, Mark E. ; Im, Seock-Ah ; Senkus, Elzbieta...
European Journal of Cancer.  184 (2023)  - p. 39-47 , 2023
Link: https://doi.org/10.1016/..
 
?
10

A second-generation antibody–drug conjugate to treat HER2-p..:

Rassy, Elie ; Delaloge, Suzette
The Lancet.  401 (2023)  10371 - p. 80-81 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Overall survival with neratinib after trastuzumab-based adj..:

Holmes, Frankie A. ; Moy, Beverly ; Delaloge, Suzette...
European Journal of Cancer.  184 (2023)  - p. 48-59 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Real-World Impact of Adjuvant Anti-HER2 Treatment on Charac..:

Le Du, Fanny ; Carton, Matthieu ; Bachelot, Thomas...
The Oncologist.  28 (2023)  10 - p. e867-e876 , 2023
Link: https://doi.org/10.1093/..
 
?
13

Insights adjusting for non-adherence in randomized clinical..:

Giudici, Fabiola ; Pistilli, Barbara ; Vaz-Luis, Ines...
British Journal of Cancer.  129 (2023)  9 - p. 1516-1523 , 2023
Link: https://doi.org/10.1038/..
 
?
14

Buffy coat signatures of breast cancer risk in a prospectiv..:

Chung, Felicia Fei-Lei ; Maldonado, Sandra González ; Nemc, Amelie...
Clinical Epigenetics.  15 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
15

Olaparib efficacy in patients with germline BRCA‐mutated, H..:

Senkus, Elżbieta ; Delaloge, Suzette ; Domchek, Susan M....
International Journal of Cancer.  153 (2023)  4 - p. 803-814 , 2023
Link: https://doi.org/10.1002/..
 
1-15